Commitments and Contingency (Details Narrative) - USD ($)			8 Months Ended	12 Months Ended
	Oct. 11, 2023	Oct. 05, 2023	Dec. 31, 2023	Dec. 31, 2024
Subsidiary, Sale of Stock [Line Items]
Over allotment option vesting period		45 days
Proceeds from issuance initial public offering			$ 69,000,000
Reimbursement of expenses				$ 690,000
Underwriters [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance initial public offering	$ 9,000,000
Shares issued			69,000	69,000
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued during period, shares, new issues		900,000
Share purchased	900,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance initial public offering	$ 69,000,000			$ 1,380,000
Percentage of underwriting discount	2.00%
Deferred fee, percentage	3.50%
IPO [Member] | Underwriting Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance initial public offering	$ 2,415,000
IPO [Member] | Underwriters [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance initial public offering	1,380,000
Reimbursement of expenses	$ 690,000